Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Dr. Reddy’s Lab launched new drug for stroke patients in India
Dr. Reddy's Laboratories Limited announced the launch of Somazina®, the innovator brand of Citicoline in the Indian market. Dr. Reddy’s has partnered with the global innovator of Citicoline, Ferrer Internacional S.A., Spain, to make Somazina® available in India. This is an important product in the management of stroke and has been used for the treatment of post-stroke patients around the world.
- Read more about It's Time to See - exclusive preview of exhibition shown to commonwealth health ministers, focusing on major cause of Avoidable Blindness - Retinopathy of Prematurity - in India
(Business Wire India); Today, at the 2015 Commonwealth Health Ministers’ Meeting in Geneva, The Queen Elizabeth Diamond Jubilee Trust and partner Standard Chartered have unveiled an exclusive preview of Time to See, a landmark photography exhibition which captures the human impact of avoidable blindness in the Commonwealth, and the solutions readily available.
- Time to See – multi-award winning photographers join forces to bring to world’s attention major causes of avoidable blindness
- 80% of world’s blindness is avoidable. Exhibition Time to See shows human impact and work being delivered by The Queen Elizabeth Diamond Jubilee Trust, Standard Chartered and partners to end avoidable blindness.
- Read more about US FDA approve breakthrough therapy designation to AbbVie's Venetoclax
AbbVie, a research-based biopharmaceutical company, has been granted breakthrough therapy designation to Venetoclax by the US FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
- Read more about Gujarat introduce India’s first mobile drug testing lab with an investment of Rs. 1 cr
By introducing mobile drug testing lab, making it the first state in the country to possess such a high tech on the go-spot-detecting drug testing laboratory. The state government invest Rs. 1 crore from the funds allocated to the Gujarat Food and Drug Control Administration (FDCA) for this purpose.
- Read more about Indian doctors evolve new surgical technique to treat severe drug resistant epilepsy
Doctors at the All India Institute of Medical Sciences (AIIMS), Delhi, have developed a novel technique of minimally invasive surgery to perform a complete unilateral hemispheric disconnection of the brain. This procedure is sometimes required for patients especially children who have severe drug resistant epilepsy.
18 May 2015

Opto Circuits introduce Powerheart G5 Automated External Defibrillator in US & Canadian markets

Opto Circuits' group company, Cardiac Science, launched newest automated external defibrillator (AED) to the US and Canadian markets. The Powerheart® G5 is the first AED to combine real-time CPR feedback, fully automatic shock delivery, variable escalating energy, and fast shock times.
- Read more about Pharma Sector to soon showcase New Drugs: Union health Min
The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, oste porosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. The candidate drugs are currently undergoing clinical trials, he said.

[adsense:336x280:8701650588]
- Read more about Biocon chairman got 2nd Rank in 'Medicine Maker Power List 2015'
Biocon’s chairman and managing director Kiran Mazumdar-Shaw, got 2nd rank in ‘The Medicine Maker Power List' 2015, an index of the 100 most influential people across the globe in the field of medicine. The top 5 in ‘The Medicine Maker Power List’ are: Anthony Fauci, director, National Institute of Allergy and Infectious Diseases, USA, Kiran Mazumdar-Shaw, chairman & managing director, Biocon, Sir Andrew Witty, chief executive officer, GlaxoSmithKline, Arthur D. Levinson, chief executive officer, Calico and Heather Bresch, chief executive officer of Mylan.
- Read more about US FDA grant Roche's cobas KRAS mutation test for diagnostic use
The US Food and Drug Administration (FDA) has approved Roche's cobas KRAS mutation test for diagnostic use. The real-time PCR test is designed to identify KRAS mutations in tumour samples from metastatic colorectal cancer (mCRC) patients and aid clinicians in determining a therapeutic path for them.
- Read more about Jubilant Life net profit lowered by 56.8% in Q4, dividend at 300%
Jubilant Life Sciences has suffered drop during the fourth quarter ended March 2015 due to lower sales and its consolidated net profit declined sharply by 56.8 per cent to Rs.42.73 crore from Rs.98.81 crore in the corresponding period of last year. Its consolidated net sales also declined by 1.9 per cent to Rs.1,523 crore from Rs.1,552 crore. EBIDTA improved marginally to Rs.253.27 crore from Rs.250.86 crore. EPS declined to Rs.2.68 from Rs.6.20 in the last period. The company management recommended equity dividend of 300 % for the year 2014-15.